Puerarin

DRUG3 trials

Sponsors

Cairo University, The University of Hong Kong, Ruijin Hospital

Conditions

Alveolar Cleft GraftingCardiovascular Disease Risk FactorsMetabolic DiseasesObesity/Therapy

Phase 2

Alveolar Cleft Grafting Using Two Different Alloplastic Grafts

Cairo UniversityAlveolar Cleft Grafting

Start: 2017-01-31End: 2017-12-31Target: 20Updated: 2017-01-11

Effect of Puerarin on Heart Health in Men

CompletedNCT03676296

The University of Hong KongCardiovascular Disease Risk Factors

Start: 2018-09-05End: 2021-04-17Updated: 2021-04-29

The Efficacy and Safety of Puerarin in Obesity Treatment

Not yet recruitingNCT06968208

Ruijin HospitalMetabolic Diseases, Obesity/Therapy

Start: 2025-08-01End: 2029-12-31Target: 80Updated: 2025-05-21